Closing Loopholes for Orphan Drugs Act
Official title: To amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Closing Loopholes for Orphan Drugs Act
This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 4538: Closing Loopholes for Orphan Drugs Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4538/
"H.R. 4538: Closing Loopholes for Orphan Drugs Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4538/.
H.R. 4538, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4538/.
[H.R. 4538: Closing Loopholes for Orphan Drugs Act](https://openamerica.io/bill/116-HR-4538/)